化学抗原受体 (CAR) 疗法用于精确根除自身免疫性病原细胞
George D Kalliolias1, Efthimia K Basdra1, Athanasios G Papavassiliou2
1Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, 11527, Greece.
Arthritis research & therapy
|December 6, 2025
概括
化学抗原受体T细胞 (CAR-T) 疗法对自身免疫性疾病具有前景. 最近的研究强调了它们在治疗系统性红斑狼和其他疾病方面的潜力,目前正在进行的研究正在探索挑战和未来的应用.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 类风湿病学 类风湿病学
背景情况:
- 化学抗原受体T细胞 (CAR-Ts) 是为向细胞杀死而设计的淋巴细胞.
- 汽车-T利用一个受体构造的特异性和效应器信号.
- 最初被批准用于血液性恶性瘤,CAR-Ts向CD19或BCMA.
研究的目的:
- 审查对自身免疫性疾病的CAR-T疗法的最新进展.
- 讨论基于CAR的疗法的转型潜力和挑战.
- 专注于2025年发布的突破性报告.
主要方法:
- 审查最近的科学文献和临床研究.
- 对针对CD19.9的自主CAR-T细胞疗法的分析.
- 专注于耐治疗的自身免疫性疾病.
主要成果:
- 针对CD19的自主CAR-T证明了在全身性红斑狼,全身性硬化症和异常性炎症性肌肉炎的安全性和有效性.
- 有证据表明,CAR-T疗法可以选择性地消除CD19+B细胞子集.
- 在治疗耐药的自身免疫性疾病中取得令人鼓舞的结果.
结论:
- 卡特-T细胞疗法为治疗严重自身免疫性疾病提供了一个有前途的途径.
- 需要进一步的研究来应对挑战并优化基于CAR的治疗方法.
- 开创性的2025报告揭示了CAR-T疗法在自身免疫性疾病管理中的未来.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K